In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction.
about
Chaperonin-containing TCP-1 complex directly binds to the cytoplasmic domain of the LOX-1 receptorPutting pleiotropy and selection into context defines a new paradigm for interpreting genetic data.Cholesterol-induced membrane microvesicles as novel carriers of damage-associated molecular patterns: mechanisms of formation, action, and detoxification.Failure to replicate an association of SNPs in the oxidized LDL receptor gene (OLR1) with CADFunctional analysis and molecular dynamics simulation of LOX-1 K167N polymorphism reveal alteration of receptor activity.Association of the LOX-1 rs1050283 Polymorphism with Risk for Atherosclerotic Cerebral Infarction and its Effect on sLOX-1 and LOX-1 Expression in a Chinese Population.Role of lectin-like oxidized low density lipoprotein-1 in fetoplacental vascular dysfunction in preeclampsiaAssociation between OLR1 K167N SNP and intima media thickness of the common carotid artery in the general population.Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular disease3'-UTR OLR1/LOX-1 gene polymorphism and endothelial dysfunction: molecular and vascular data in never-treated hypertensive patients.Gene expression analyses implicate an alternative splicing program in regulating contractile gene expression and serum response factor activity in mice.The discovery of LOX-1, its ligands and clinical significance.Overexpression of scavenger receptor LOX-1 in endothelial cells promotes atherogenesis in the ApoE(-/-) mouse model.Role of six single nucleotide polymorphisms, risk factors in coronary disease, in OLR1 alternative splicingEfficacy of Oral Curcuminoid Fraction from Curcuma xanthorrhiza and Curcuminoid Cider in High-cholesterol Fed RatsMolecular genetics of myocardial infarctionLectin-like oxidized low-density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis?The lectin-like oxidized LDL receptor-1: a new potential molecular target in colorectal cancerVariation in the human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1) gene is associated with plasma soluble LOX-1 levels.RNA binding proteins in the regulation of heart development.Alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme A reductase is associated with plasma low-density lipoprotein cholesterol response to simvastatinThe role of HMGCR alternative splicing in statin efficacy.LOX-1 and Its Splice Variants: A New Challenge for Atherosclerosis and Cancer-Targeted Therapies.LOX-1: a critical player in the genesis and progression of myocardial ischemia.LOX-1/LOXIN: the yin/yang of atheroscleorosis.The C-type lectin-like receptors of Dectin-1 cluster in natural killer gene complex.Lectin-like oxidized low-density lipoprotein receptor 1 pathways.The lectin-like oxidized low-density lipoprotein receptor-1 as therapeutic target for atherosclerosis, inflammatory conditions and longevity.LOX-1, a new marker of risk and prognosis in coronary artery disease?LOX-1, OxLDL, and atherosclerosisThe role of lectin-like oxidised low-density lipoprotein receptor-1 in vascular pathology.Associations between oxidized-lipoprotein receptor 1 G501C and 3'-UTR-C188T polymorphisms and coronary artery disease: a meta-analysis.Histone deacetylase-high mobility group box-1 pathway targeted by hypaconitine suppresses the apoptosis of endothelial cells.The LOX-1 Scavenger Receptor and Its Implications in the Treatment of Vascular DiseaseThe human rs1050286 polymorphism alters LOX-1 expression through modifying miR-24 binding.Effect of IL-10 on LOX-1 expression, signalling and functional activity: an atheroprotective response.The hydrophobic tunnel present in LOX-1 is essential for oxidized LDL recognition and binding.LOX-1 receptor blockade abrogates oxLDL-induced oxidative DNA damage and prevents activation of the transcriptional repressor Oct-1 in human coronary arterial endothelium.Oxidized LDL receptor 1 gene polymorphism in patients with metabolic syndrome.Population differences in allele frequencies at theOLR1locus may suggest geographic disparities in cardiovascular risk events
P2860
Q24297988-5F3813EB-69F1-44B3-A1B8-5217972FF286Q30619838-2A6E37D5-5B36-4978-BD73-6BFCA0C650A0Q30664287-000AF639-99D2-4E06-ADF5-720CEA7B721BQ33326760-69C6CABF-5D93-48B5-8055-ECDCA31F943BQ33413089-FFD43305-90A8-4104-890F-874CE40ED78EQ33752266-C89FE459-F33F-4346-A603-FF7BFB3AA124Q33944749-64A46E8C-4D60-447A-8053-571B04DA417AQ34162711-D4513C1E-8067-4389-8D84-51172EE698CFQ34218552-EEF183C0-44D2-48B7-856F-1A7F10A0071DQ34440283-81DD476D-8852-4880-8985-8F2EBEC4B913Q34599059-D7E79919-C892-4942-A327-D5074DD3CD84Q35475499-FCB95BF3-B80A-4D01-BD35-D805888A7FF2Q35502017-2C2E189B-5F45-4367-A1A7-E573EC0868A4Q35621461-8D35D1D5-DD7C-44B8-B64C-C8570D27D7B8Q36065575-0E71802B-A228-4010-863F-C57800BF6A9DQ36843011-74C7FEE1-5369-4754-B403-B029182BADBDQ36872076-311A28AD-405B-44B1-84AF-E85ED130115DQ37046713-4338E915-164C-4D8C-8FB2-C079E847570BQ37119512-BAF075E4-5AD5-4D9D-9BC2-EFFB39DC9D29Q37245183-E9EA4B0C-CE26-42F2-AB3E-4C80303B691BQ37287003-601A9CBC-3FBB-44EC-9C57-585FBD237E4AQ37652284-41320366-FB8A-4775-B669-61E9ACD0AA07Q37690728-37CA42D3-AD96-4AED-A3FF-83CE169AD637Q37918860-A8E89901-B137-43B1-9615-79059AF58359Q37929625-4AAF9275-D8FF-4198-A543-7604AD6FD050Q38025997-58F5AE4B-1619-465F-AF16-DA23362B1BF6Q38099693-64EC1F6F-A08C-4AF1-B95A-5AA89236A3B1Q38112162-0D20F1B7-4E52-4FAF-BBA6-2B2FF047A59DQ38128195-D82A7BC4-DB7D-4AB6-A1D6-C61B83F52CBCQ38128283-7B57ABD9-AFC8-4029-93A4-69E36594A1A9Q38248729-37D3C3C8-DDFE-4F16-81AC-8F45AA229790Q38421117-0008D3C5-3002-49BB-B2A0-DD7EEAAA56CAQ38722806-9FB5121A-05DA-4143-A5B6-01EEEAF42141Q42011629-113216CA-4901-4570-B12C-7238D750094DQ42108366-FB5502F4-577D-4D6E-ABCF-2F776FE32746Q45908838-95C60E6F-9E5A-40F8-992E-B64D23C179FEQ46323055-8BBB1550-B561-4131-BDCC-2F6DDD5B1265Q46662739-0946C40A-2FE8-4E41-9ADD-332044C02286Q51349361-8F5EC538-726B-4CCA-8B62-43AD0AADDCFBQ58272681-06F699B9-CD15-4213-862C-BDDA81CD81F8
P2860
In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
In vivo and in vitro studies s ...... t acute myocardial infarction.
@en
In vivo and in vitro studies s ...... t acute myocardial infarction.
@nl
type
label
In vivo and in vitro studies s ...... t acute myocardial infarction.
@en
In vivo and in vitro studies s ...... t acute myocardial infarction.
@nl
prefLabel
In vivo and in vitro studies s ...... t acute myocardial infarction.
@en
In vivo and in vitro studies s ...... t acute myocardial infarction.
@nl
P2093
P50
P1433
P1476
In vivo and in vitro studies s ...... t acute myocardial infarction.
@en
P2093
Antonio Filareto
Cartesio Favalli
Fabrizio Clementi
Francesca del Vecchio
Francesco Romeo
Ilaria Filesi
Jawahar L Mehta
Paola Spitalieri
Renato Lauro
Ruggiero Mango
P304
P356
10.1161/01.RES.0000174563.62625.8E
P577
2005-06-23T00:00:00Z